{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:22:50Z","timestamp":1789050170926,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chinese olive contains plenty of polyphenols, which possess a wide range of biological actions. In this study, we aimed to investigate the role of the ethyl acetate fraction of Chinese olive fruit extract (CO-EtOAc) in the modulation of lipid accumulation\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . In cellular studies, CO-EtOAc attenuated oleic acid-induced lipid accumulation; we then elucidated the molecular mechanisms of CO-EtOAc in FL83B mouse hepatocytes. CO-EtOAc suppressed the mRNA levels of fatty acid transporter genes (\n                    <jats:italic>CD36<\/jats:italic>\n                    and\n                    <jats:italic>FABP<\/jats:italic>\n                    ) and lipogenesis genes (\n                    <jats:italic>SREBP-1c<\/jats:italic>\n                    ,\n                    <jats:italic>FAS<\/jats:italic>\n                    , and\n                    <jats:italic>ACC1<\/jats:italic>\n                    ), but upregulated genes that govern lipolysis (\n                    <jats:italic>HSL<\/jats:italic>\n                    ) and lipid oxidation (\n                    <jats:italic>PPAR\u03b1<\/jats:italic>\n                    ,\n                    <jats:italic>CPT-1<\/jats:italic>\n                    , and\n                    <jats:italic>ACOX<\/jats:italic>\n                    ). Moreover, CO-EtOAc increased the protein expression of phosphorylated AMPK, ACC1, CPT-1, and PPAR\u03b1, but downregulated the expression of mature SREBP-1c and FAS. AMPK plays an essential role in CO-EtOAc-mediated amelioration of lipid accumulation. Furthermore, we confirmed that CO-EtOAc significantly inhibited body weight gain, epididymal adipose tissue weight, and hepatic lipid accumulation via regulation of the expression of fatty acid transporter, lipogenesis, and fatty acid oxidation genes and proteins in C57BL\/6 mice fed a 60% high-fat diet. Therefore, Chinese olive fruits may have the potential to improve the metabolic abnormalities associated with fatty liver under high fat challenge.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-19553-1","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T06:08:27Z","timestamp":1515737307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism"],"prefix":"10.1038","volume":"8","author":[{"given":"Yu-Te","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Na","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"19553_CR1","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jnutbio.2013.06.003","volume":"24","author":"PV Babu","year":"2013","unstructured":"Babu, P. V., Liu, D. & Gilbert, E. R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 24, 1777\u20131789 (2013).","journal-title":"J. Nutr. Biochem."},{"key":"19553_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.phymed.2007.06.001","volume":"14","author":"AM Kountouri","year":"2007","unstructured":"Kountouri, A. M., Mylona, A., Kaliora, A. C. & Andrikopoulos, N. K. Bioavailability of the phenolic compounds of the fruits (drupes) of Olea europaea (olives): impact on plasma antioxidant status in humans. Phytomedicine 14, 659\u2013667 (2007).","journal-title":"Phytomedicine"},{"key":"19553_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/ijms18050930","volume":"18","author":"F Echeverria","year":"2017","unstructured":"Echeverria, F., Ortiz, M., Valenzuela, R. & Videla, L. A. Hydroxytyrosol and Cytoprotection: A Projection for Clinical Interventions. Int. J. Mol. Sci. 18, 930 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"19553_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00217-008-0939-2","volume":"228","author":"ZY He","year":"2009","unstructured":"He, Z. Y., Xia, W. S., Liu, Q. H. & Chen, J. Identification of a new phenolic compound from Chinese olive (Canarium album L.) fruit. Eur. Food Res. Technol. 228, 339\u2013343 (2009).","journal-title":"Eur. Food Res. Technol."},{"key":"19553_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/1574887109666141216111143","volume":"9","author":"M Masarone","year":"2014","unstructured":"Masarone, M., Federico, A., Abenavoli, L., Loguercio, C. & Persico, M. Non alcoholic fatty liver: epidemiology and natural history. Rev. Recent. Clin. Trials 9, 126\u2013133 (2014).","journal-title":"Rev. Recent. Clin. Trials"},{"key":"19553_CR6","doi-asserted-by":"publisher","first-page":"25168","DOI":"10.3390\/ijms161025168","volume":"16","author":"MC Hernandez-Rodas","year":"2015","unstructured":"Hernandez-Rodas, M. C., Valenzuela, R. & Videla, L. A. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 16, 25168\u201325198 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"19553_CR7","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.foodchem.2013.05.019","volume":"141","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 141, 2108\u20132116 (2013).","journal-title":"Food Chem."},{"key":"19553_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.plefa.2015.04.002","volume":"98","author":"R Valenzuela","year":"2015","unstructured":"Valenzuela, R. et al. Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: Relation to LCPUFA depletion in liver and extrahepatic tissues. Prostaglandins Leukot. Essent. Fatty Acids 98, 7\u201314 (2015).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"19553_CR9","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1159\/000447866","volume":"39","author":"AM Hetherington","year":"2016","unstructured":"Hetherington, A. M. et al. Differential lipotoxic effects of palmitate and oleate in activated human hepatic stellate cells and epithelial hepatoma cells. Cell Physiol. Biochem. 39, 1648\u20131662 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"19553_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","volume":"19","author":"SH Koo","year":"2013","unstructured":"Koo, S. H. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin. Mol. Hepatol. 19, 210\u2013215 (2013).","journal-title":"Clin. Mol. Hepatol."},{"key":"19553_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","volume":"20","author":"X Su","year":"2009","unstructured":"Su, X. & Abumrad, N. A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 20, 72\u201377 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"19553_CR12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/j.gastro.2006.02.006","volume":"130","author":"H Doege","year":"2006","unstructured":"Doege, H. et al. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 130, 1245\u20131258 (2006).","journal-title":"Gastroenterology"},{"key":"19553_CR13","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.1152\/ajpendo.00226.2010","volume":"299","author":"A Falcon","year":"2010","unstructured":"Falcon, A. et al. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am. J. Physiol. Endocrinol. Metab. 299, E384\u2013E393 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"19553_CR14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","volume":"56","author":"G Wang","year":"2015","unstructured":"Wang, G., Bonkovsky, H. L., de Lemos, A. & Burczynski, F. J. Recent insights into the biological functions of liver fatty acid binding protein 1. J. Lipid Res. 56, 2238\u20132247 (2015).","journal-title":"J. Lipid Res."},{"key":"19553_CR15","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db07-0907","volume":"56","author":"DP Koonen","year":"2007","unstructured":"Koonen, D. P. et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56, 2863\u20132871 (2007).","journal-title":"Diabetes"},{"key":"19553_CR16","doi-asserted-by":"publisher","first-page":"32523","DOI":"10.1074\/jbc.M003826200","volume":"27","author":"CT Coburn","year":"2000","unstructured":"Coburn, C. T. et al. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 27, 32523\u201332529 (2000).","journal-title":"J. Biol. Chem."},{"key":"19553_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18632\/aging.100652","volume":"6","author":"F Sheedfar","year":"2014","unstructured":"Sheedfar, F. et al. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging-Us 6, 281\u2013295 (2014).","journal-title":"Aging-Us"},{"key":"19553_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3109\/00365521.2013.836754","volume":"49","author":"JB Suh","year":"2014","unstructured":"Suh, J. B., Kim, S. M., Cho, G. J. & Choi, K. M. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. Scand. J. Gastroenterol 49, 979\u2013985 (2014).","journal-title":"Scand. J. Gastroenterol"},{"key":"19553_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0167-4889(92)90203-N","volume":"1137","author":"PM Baldini","year":"1992","unstructured":"Baldini, P. M., Zannetti, A., Donchenko, V., Dini, L. & Luly, P. Insulin effect on isolated rat hepatocytes: diacylglycerol-phosphatidic acid interrelationship. Biochim. Biophys. Acta. 1137, 208\u2013214 (1992).","journal-title":"Biochim. Biophys. Acta."},{"key":"19553_CR20","doi-asserted-by":"crossref","unstructured":"Ntambi, J. M. Hepatic de novo lipogenesis and regulation of metabolism. Springer: New York, NY, USA, (2015).","DOI":"10.1007\/978-3-319-25065-6"},{"key":"19553_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri, P. et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081\u20131090 (2007).","journal-title":"Hepatology"},{"key":"19553_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/MEG.0b013e3282f9b203","volume":"20","author":"K Morgan","year":"2008","unstructured":"Morgan, K. et al. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 20, 843\u2013854 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"19553_CR23","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0505714102","volume":"102","author":"L Abu-Elheiga","year":"2005","unstructured":"Abu-Elheiga, L. et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc. Natl. Acad. Sci. USA 102, 12011\u201312016 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19553_CR24","first-page":"505","volume":"3","author":"C Dorn","year":"2010","unstructured":"Dorn, C. et al. Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int. J. Clin. Exp. Pathol. 3, 505\u2013514 (2010).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"19553_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125\u20131131 (2002).","journal-title":"J. Clin. Invest."},{"key":"19553_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2007.10.009","volume":"19","author":"R Raghow","year":"2008","unstructured":"Raghow, R., Yellaturu, C., Deng, X., Park, E. A. & Elam, M. B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol. Metab. 19, 65\u201373 (2008).","journal-title":"Trends Endocrinol. Metab."},{"key":"19553_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147\u2013152 (2004).","journal-title":"J. Clin. Invest."},{"key":"19553_CR28","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2337\/db07-0156","volume":"56","author":"J Westerbacka","year":"2007","unstructured":"Westerbacka, J. et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56, 2759\u20132765 (2007).","journal-title":"Diabetes"},{"key":"19553_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1126\/science.1100747","volume":"306","author":"R Zimmermann","year":"2004","unstructured":"Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383\u20131386 (2004).","journal-title":"Science"},{"key":"19553_CR30","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1074\/jbc.M110355200","volume":"277","author":"G Haemmerle","year":"2002","unstructured":"Haemmerle, G. et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem. 277, 4806\u20134815 (2002).","journal-title":"J. Biol. Chem."},{"key":"19553_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","volume":"175","author":"GF Grabner","year":"2017","unstructured":"Grabner, G. F., Zimmermann, R., Schicho, R. & Taschler, U. Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling. Pharmacol. Ther. 175, 35\u201346 (2017).","journal-title":"Pharmacol. Ther."},{"key":"19553_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1113\/jphysiol.2005.102178","volume":"571","author":"GP Holloway","year":"2006","unstructured":"Holloway, G. P. et al. Mitochondrial long chain fatty acid oxidation, fatty acid translocase\/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J. Physiol. 571, 201\u2013210 (2006).","journal-title":"J. Physiol."},{"key":"19553_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2009.02.004","volume":"60","author":"M Yoon","year":"2009","unstructured":"Yoon, M. The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol. Res. 60, 151\u2013159 (2009).","journal-title":"Pharmacol. Res."},{"key":"19553_CR34","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2337\/db12-1397","volume":"62","author":"SM Chan","year":"2013","unstructured":"Chan, S. M. et al. Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 62, 2095\u20132105 (2013).","journal-title":"Diabetes"},{"key":"19553_CR35","doi-asserted-by":"publisher","first-page":"42477","DOI":"10.1038\/srep42477","volume":"7","author":"Y Honda","year":"2017","unstructured":"Honda, Y. et al. Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. Sci. Rep. 7, 42477\u201342486 (2017).","journal-title":"Sci. Rep."},{"key":"19553_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","volume":"196","author":"B Viollet","year":"2009","unstructured":"Viollet, B. et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol. 196, 81\u201398 (2009).","journal-title":"Acta Physiol."},{"key":"19553_CR37","doi-asserted-by":"publisher","first-page":"14734","DOI":"10.1074\/jbc.M808664200","volume":"284","author":"R Kou","year":"2009","unstructured":"Kou, R., Sartoretto, J. & Michel, T. Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta. J. Biol. Chem. 284, 14734\u201314743 (2009).","journal-title":"J. Biol. Chem."},{"key":"19553_CR38","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1242\/jcs.01540","volume":"117","author":"DG Hardie","year":"2004","unstructured":"Hardie, D. G. The AMP-activated protein kinase pathway\u2013new players upstream and downstream. J. Cell Sci. 117, 5479\u20135487 (2004).","journal-title":"J. Cell Sci."},{"key":"19553_CR39","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI29044","volume":"116","author":"YC Long","year":"2006","unstructured":"Long, Y. C. & Zierath, J. R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116, 1776\u20131783 (2006).","journal-title":"J. Clin. Invest."},{"key":"19553_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2010.09.014","volume":"54","author":"M Foretz","year":"2011","unstructured":"Foretz, M. & Viollet, B. Regulation of hepatic metabolism by AMPK. J. Hepatol. 54, 827\u2013829 (2011).","journal-title":"J. Hepatol."},{"key":"19553_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"19553_CR42","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","volume":"54","author":"B Staels","year":"2005","unstructured":"Staels, B. & Fruchart, J. C. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460\u20132470 (2005).","journal-title":"Diabetes"},{"key":"19553_CR43","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1194\/jlr.R025882","volume":"53","author":"RA Srivastava","year":"2012","unstructured":"Srivastava, R. A. et al. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J. Lipid Res. 53, 2490\u20132514 (2012).","journal-title":"J. Lipid Res."},{"key":"19553_CR44","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/db13-0368","volume":"62","author":"DG Hardie","year":"2013","unstructured":"Hardie, D. G. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62, 2164\u20132172 (2013).","journal-title":"Diabetes"},{"key":"19553_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/S0029665115004218","volume":"75","author":"I Rodriguez-Ramiro","year":"2016","unstructured":"Rodriguez-Ramiro, I., Vauzour, D. & Minihane, A. M. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proc. Nutr. Soc. 75, 47\u201360 (2016).","journal-title":"Proc. Nutr. Soc."},{"key":"19553_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"2","author":"KB Pandey","year":"2009","unstructured":"Pandey, K. B. & Rizvi, S. I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev. 2, 270\u2013278 (2009).","journal-title":"Oxid. Med. Cell Longev."},{"key":"19553_CR47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.foodchem.2007.04.049","volume":"105","author":"Z He","year":"2007","unstructured":"He, Z. & Xia, W. Analysis of phenolic compounds in Chinese olive (Canarium album L.) fruit by RPHPLC-DAD-ESI-MS. Food Chem. 105, 1307\u20131311 (2007).","journal-title":"Food Chem."},{"key":"19553_CR48","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/nu9101123","volume":"9","author":"YT Yeh","year":"2017","unstructured":"Yeh, Y. T., Chiang, A. N. & Hsieh, S. C. Chinese Olive (Canarium album L.) Fruit extract attenuates metabolic dysfunction in diabetic rats. Nutrients 9, 1123\u20131140 (2017).","journal-title":"Nutrients"},{"key":"19553_CR49","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s13197-014-1267-0","volume":"51","author":"M Singh","year":"2014","unstructured":"Singh, M. et al. Influence of the solvents on the extraction of major phenolic compounds (punicalagin, ellagic acid and gallic acid) and their antioxidant activities in pomegranate aril. J. Food Sci. Technol. 51, 2070\u20132077 (2014).","journal-title":"J. Food Sci. Technol."},{"key":"19553_CR50","doi-asserted-by":"publisher","first-page":"18832","DOI":"10.1073\/pnas.1309469110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 110, 18832\u201318837 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19553_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","volume":"165","author":"MJ Gomez-Lechon","year":"2007","unstructured":"Gomez-Lechon, M. J. et al. A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact. 165, 106\u2013116 (2007).","journal-title":"Chem. Biol. Interact."},{"key":"19553_CR52","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri, P. et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50, 1827\u20131838 (2009).","journal-title":"Hepatology"},{"key":"19553_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/CS20030326","volume":"106","author":"J Araya","year":"2004","unstructured":"Araya, J. et al. Increase in long-chain polyunsaturated fatty acid n-6\/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. 106, 635\u2013643 (2004).","journal-title":"Clin. Sci."},{"key":"19553_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BST0390001","volume":"39","author":"DG Hardie","year":"2011","unstructured":"Hardie, D. G. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem. Soc. Trans. 39, 1\u201313 (2011).","journal-title":"Biochem. Soc. Trans."},{"key":"19553_CR55","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jnutbio.2010.06.005","volume":"22","author":"L Vila","year":"2011","unstructured":"Vila, L. et al. Liver AMP\/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J. Nutr. Biochem. 22, 741\u2013751 (2011).","journal-title":"J. Nutr. Biochem."},{"key":"19553_CR56","first-page":"823","volume":"9","author":"M Zhang","year":"2017","unstructured":"Zhang, M. et al. Protective benefits of AMP-activated protein kinase in hepatic ischemia-reperfusion injury. Am. J. Transl. Res. 9, 823\u2013829 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"19553_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","volume":"12","author":"P Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9, P. & Foufelle, F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Metab. 12, 83\u201392 (2010).","journal-title":"Diabetes Obes. Metab."},{"key":"19553_CR58","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","volume":"27","author":"N Mendez-Sanchez","year":"2007","unstructured":"Mendez-Sanchez, N., Arrese, M., Zamora-Valdes, D. & Uribe, M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int. 27, 423\u2013433 (2007).","journal-title":"Liver Int."},{"key":"19553_CR59","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125\u20131131 (2002).","journal-title":"J. Clin. Invest."},{"key":"19553_CR60","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano, Y. & Cohen, D. E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 48, 434\u2013441 (2013).","journal-title":"J. Gastroenterol."},{"key":"19553_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.med.60.101107.134820","volume":"61","author":"G Musso","year":"2010","unstructured":"Musso, G., Gambino, R. & Cassader, M. Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. Annu. Rev. Med. 61, 375\u2013392 (2010).","journal-title":"Annu. Rev. Med."},{"key":"19553_CR62","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acsmedchemlett.5b00275","volume":"6","author":"A Abdel-Magid","year":"2015","unstructured":"Abdel-Magid, A. Fatty acid synthase (FASN) inhibitors as potential treatment for cancer, obesity, and liver related disorders. ACS Med. Chem. Lett. 6, 838\u2013839 (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"19553_CR63","doi-asserted-by":"publisher","first-page":"G164","DOI":"10.1152\/ajpgi.00369.2013","volume":"307","author":"AL McIntosh","year":"2014","unstructured":"McIntosh, A. L. et al. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-\u03b1 activation in cultured human female hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G164\u2013G176 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"19553_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","volume":"3","author":"S Kersten","year":"2014","unstructured":"Kersten, S. Integrated physiology and systems biology of PPAR\u03b1. Mol. Metab. 3, 354\u2013371 (2014).","journal-title":"Mol. Metab."},{"key":"19553_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02360-5","volume":"7","author":"Z Dong","year":"2017","unstructured":"Dong, Z. et al. Astragaloside IV alleviates heart failure via activating PPAR\u03b1 to switch glycolysis to fatty acid \u03b2-oxidation. Sci. Rep. 7, 2691 (2017).","journal-title":"Sci. Rep."},{"key":"19553_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ptr.5741","volume":"31","author":"B Kim","year":"2017","unstructured":"Kim, B. et al. Hovenia dulcis extract reduces lipid accumulation in oleic acid-induced steatosis of Hep G2 cells via activation of AMPK and PPAR\u03b1\/CPT-1 pathway and in acute hyperlipidemia mouse model. Phytother. Res. 31, 132\u2013139 (2017).","journal-title":"Phytother. Res."},{"key":"19553_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.fct.2013.04.018","volume":"58","author":"N Ziamajidi","year":"2013","unstructured":"Ziamajidi, N. et al. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH) via modulation of PPAR\u03b1 and SREBP-1. Food Chem. Toxicol. 58, 198\u2013209 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"19553_CR68","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.nut.2016.04.006","volume":"32","author":"MA Rinc\u00f3n-Cervera","year":"2016","unstructured":"Rinc\u00f3n-Cervera, M. A. et al. Supplementation with antioxidant-rich extra virgin olive oil prevents hepatic oxidative stress and reduction of desaturation capacity in mice fed a high-fat diet: Effects on fatty acid composition in liver and extrahepatic tissues. Nutrition 32, 1254\u20131267 (2016).","journal-title":"Nutrition"},{"key":"19553_CR69","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1039\/C5FO01086A","volume":"7","author":"R Valenzuela","year":"2016","unstructured":"Valenzuela, R. et al. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. Food Funct. 7, 140\u2013150 (2016).","journal-title":"Food Funct."},{"key":"19553_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ab.2013.10.001","volume":"445","author":"MJ Deutsch","year":"2014","unstructured":"Deutsch, M. J., Schriever, S. C., Roscher, A. A. & Ensenauer, R. Digital image analysis approach for lipid droplet size quantitation of Oil Red O-stained cultured cells. Anal. Biochem. 445, 87\u201389 (2014).","journal-title":"Anal. Biochem."},{"key":"19553_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"19553_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0041-008X(90)90278-3","volume":"104","author":"CP LeBel","year":"1990","unstructured":"LeBel, C. P., Ali, S. F., McKee, M. & Bondy, S. C. Organometal-induced increases in oxygen reactive species: the potential of 2\u2032,7\u2032-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 104, 17\u201324 (1990).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"19553_CR73","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351\u2013358 (1979).","journal-title":"Anal. Biochem."},{"key":"19553_CR74","doi-asserted-by":"publisher","first-page":"32081","DOI":"10.1074\/jbc.M502876200","volume":"280","author":"A Hahn-Windgassen","year":"2005","unstructured":"Hahn-Windgassen, A. et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 280, 32081\u201332089 (2005).","journal-title":"J. Biol. Chem."},{"key":"19553_CR75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19553-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:14:25Z","timestamp":1671567265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19553-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1057"}}